A drug repurposing approach for antimalarials interfering with SARS-COV-2 spike protein receptor binding domain (RBD) and human angiotensin-converting enzyme 2 (ACE2)
Paolo Coghi, Li Jun Yang, Jerome P.L. Ng, Richard K. Haynes, Maurizio Memo, Alessandra Gianoncelli, Vincent Kam Wai Wong, Giovanni Ribaudo
Dive into the research topics of 'A drug repurposing approach for antimalarials interfering with SARS-COV-2 spike protein receptor binding domain (RBD) and human angiotensin-converting enzyme 2 (ACE2)'. Together they form a unique fingerprint.